Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Open accessThe DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease in midlife. The phenotypic spectrum, however, ranges from in utero onset to adequate renal function at old age. Recent patient data suggest that the disease is dosage dependent, where incompletely penetrant alleles influence disease severity. Here, we have developed a knockin mouse model matching a likely disease variant, PKD1 p.R3277C (RC), and have proved that its functionally hypomorphic nature modifies the ADPKD phenotype. While Pkd1+/null mice are normal, Pkd1RC/null mice have rapidly progressive disease, and Pkd1RC/RC animals develop gradual cystogenesis. These models effectively mimic the pathophysiological features of in utero-onset and typical ADPKD, respectively, correlating the level of functional Pkd1 product with disease severity, highlighting the dosage dependence of cystogenesis. Additionally, molecular analyses identified p.R3277C as a temperature-sensitive folding/trafficking mutant, and length defects in collecting duct primary cilia, the organelle central to PKD pathogenesis, were clearly detected for the first time to our knowledge in PKD1. Altogether, this study highlights the role that in trans variants at the disease locus can play in phenotypic modification of dominant diseases and provides a truly orthologous PKD1 model, optimal for therapeutic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [427]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and proteomic profiling of exosomes in human urine
Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403453101 · Cited by 2,174 · cited 2×
“21, 22).”
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057 · cited 2×
“However, in PKD1, the majority of studies have not detected cilia length defects, but the data are not conclusive, as these studies were largely conducted by light microscopy using cultured cells (14, 15, 80, 81).”
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationPKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406 · cited 1×
“3) and PKD2 (4q21), mutated in approximately 85% and 15% of cases, respectively (3–5).”
Hildebrandt, F., Benzing, T., & Katsanis, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010172 · Cited by 1,331
A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations
Liu, P., Jenkins, N. A., & Copeland, N. G. (2003) · Genome Research · doi:10.1101/gr.749203 · Cited by 1,013 · cited 1×
“A β -lactamase expression cassette flanked with a 3 ′ Sal I site was recom-bineered into IVS30, using the DY380 E. coli strain (63).”
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910 · cited 1×
“82, 83).”
Self-citationDise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818 · cited 1×
“One possibility is that the PC complex acts as a mechanosensor, signaling via a Ca 2+ influx through PC-2, a TRP channel, after fluid flow detection by PC-1 (14, 16, 20).”
Cited by
Items 301–400 of 480
Atwood, D. J., He, Z., Miyazaki, M., Hailu, F. T., Klawitter, J., & Edelstein, C. L. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111351 · Cited by 6
Jansson, K. P., Kuluva, J., Zhang, S., Swanson, T., Zhang, Y., Zimmerman, K. A., Fields, T. A., Wallace, D. P., Rowe, P. S., & Stubbs, J. R. (2024) · Physiological Reports · doi:10.14814/phy2.70038 · Cited by 5
“The RC/RC strain (used to validate kidney OPN expression patterns in PKD) is a murine model exhibiting a clinically relevant mutation in the Pkd1 gene that drives the production of a mutant polycystin-1 protein and results in the development of slowly-progressive PKD (Hopp et al., 2012).”
BackgroundNotch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
Ren, H., Mu, C., Wang, Y., Yuanyuan, C., Hou, Y., Li, Y., Liu, N., Yin, Z., Xiong, H., Chen, Y., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000592 · Cited by 5
Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
Holmes, H. L., Stiller, A. A., Moore, C. J., Gregory, A., Roos, C. M., Miller, J. D., Gessner, R. C., Czernuszewicz, T. J., Kline, T. L., & Romero, M. F. (2021) · Journal of Visualized Experiments · doi:10.3791/62682 · Cited by 5
Trant, J., Sánchez, G., McDermott, J. P., & Blanco, G. V. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00056.2023 · Cited by 5
Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease
VanNoy, G. E., Wojcik, M. H., Genetti, C. A., Mullen, T. E., Agrawal, P. B., & Stein, D. R. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.05.008 · Cited by 5
“4 However, further research in mice with reduced Pkd1 expression has established a dosedependent model of disease, suggesting that modifier alleles may contribute to the severity and onset of cyst development.(5,6) Multiple studies of families with ADPKD have implicated variants in PKD1, PKD2, PKHD1, or HNF1B inherite…”
BackgroundChandra, A. N., Saravanabavan, S., & Rangan, G. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910512 · Cited by 5
Novel Treatments for Polycystic Kidney Disease
Patil, A., Sweeney, W. E., Pan, C. G., & Avner, E. D. (2019) · Translational Science of Rare Diseases · doi:10.3233/trd-190040 · Cited by 5
“These include: 1) the developmental timing of PKD1 inactivation [32–35]; 2) reduction in functional PC1 levels [20, 22, 36, 37]; and 3) one cyst among neighboring cells and nephrons can create a toxic environment resulting in a “snowball effect” leading to cyst development in neighboring nephrons [38].”
BackgroundPreval, K. M., Smith, A. O., & Pazour, G. J. (2025) · Journal of Cellular Signaling · doi:10.33696/signaling.6.144 · Cited by 4
“This allele, derived from a human patient, is hypomorphic, and mice homozygous for this allele develop a slow-progressing cystic phenotype [47].”
Wu, S.-S., Hung, P.-Y., Yeh, T. Y., Lin, P.-J., Chern, J., & Yu, C. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03139 · Cited by 4
Basigin Deficiency Induces Spontaneous Polycystic Kidney in Mice
Zhong, F., Li, W., Zhao, C., Jin, L., Lu, X., Zhao, Y., Pu, J., & Ge, H. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21486 · Cited by 4
MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study
Lai, S., Mastroluca, D., Perrotta, A. M., Muscaritoli, M., Lucciola, S., Felli, M. P., Izzo, P., Rotondi, S., Izzo, S., Tartaglione, L., et al. (2024) · Journal of Nephrology · doi:10.1007/s40620-024-01965-0 · Cited by 4
“The progressive interstitial fibrosis could be the result of cortical ischemia produced by the vascular lesions and luminal narrowing [4, 5].”
Netrin-1 Overexpression Induces Polycystic Kidney Disease
Mohamed, R., Liu, Y., Kistler, A. D., Harris, P. C., & Thangaraju, M. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.03.004 · Cited by 4
Self-citationAutosomal Dominant Polycystic Kidney Disease
Somlo, S., Torres, V. E., & Caplan, M. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00080-x · Cited by 4
Self-citationRangan, G. K., Raghubanshi, A., Chaitarvornkit, A., Chandra, A. N., Gardos, R., Munt, A., Read, M. N., Saravanabavan, S., Zhang, J. Q. J., & Wong, A. T. Y. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1804859 · Cited by 4
A common intronic single nucleotide variant modifies PKD1 expression level
Zhang, Z., Blumenfeld, J. D., Ramnauth, A., Barash, I., Zhou, P., Levine, D. M., Parker, T. S., & Rennert, H. (2022) · Clinical Genetics · doi:10.1111/cge.14214 · Cited by 4
“gene dosage was reported in orthologous ADPKD models and patients with incompletely penetrant hypomorphic alleles that reduced the level of PKD1/2 gene expression and caused mild-tosevere ADPKD, with a phenotype that can be indistinguishable from a “two-hit” mechanism.(13,16,17) Genes that are crucial to human fitness…”
BackgroundValidation of the ACMG/AMP guidelines-based seven-category variant classification systemPreprint
Chen, J., Masson, E., Zou, W., Liao, Z., Génin, E., Cooper, D. N., & Férec, C. (2023) · medRxiv · doi:10.1101/2023.01.23.23284909 · Cited by 4
“The homozygous knock-in mice were estimated to exhibit 221 ~40% of the Pkd1 function of wild-type mice [43].”
BackgroundKcnn4/KCa3.1 inhibition blunts polycystic kidney disease progression in mouse models
Yao, G., Kurbegovic, A., Parrot, C., Foley, W., Roman, W., Alper, S. L., & Trudel, M. (2025) · JCI Insight · doi:10.1172/jci.insight.191311 · Cited by 3
“Our consistent findings of elevated renal cAMP content in tested Pkd1 mouse models reinforces original observations of increased cAMP in cultured human cyst epithelial cells (92) and in the Pkd1 RC/RC mouse model of ADPKD (93).”
A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia
Chen, C., Wang, Z., Gao, Y., Ellis, M. R., Ji, B., Sieben, C. J., Haycraft, C. J., Croyle, M. J., Aghevli, A., Xu, Q., et al. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000942 · Cited by 3
Self-citationPirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease
Remadevi, V., Jamadar, A., Varghese, M. M., Yang, H., Gunewardena, S., Wallace, D. P., & Rao, R. (2026) · JCI Insight · doi:10.1172/jci.insight.207552 · Cited by 3
Yilmaz, G., Singha, S. K., Savaliya, B., Abdelfattah, A., Elsekaily, W., Xu, X., Zhang, Y., Hanna, C., Hogan, M. C., Chade, A., et al. (2026) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00266.2025 · Cited by 3
Designing genome editing experiments with EditABLE
Maxim, D. S., Sostena, J., Johnson, N. S., Wu, D. W., Charu, V., Carter, J. N., Anand, S., Church, G. M., & Bhalla, V. (2026) · Genome biology · doi:10.1186/s13059-026-04095-x · Cited by 3
Autosomal dominant polycystic kidney disease diagnosed in utero. Review
Nowak, M., Huras, H. K., Wiechec, M. T., Jach, R., Radoń-Pokracka, M., & Górecka, J. (2016) · Ginekologia Polska · doi:10.5603/gp.2016.0053 · Cited by 3
Guarnaroli, M., Padoan, F., Fava, C., Benetti, M. G., Brugnara, M., Pietrobelli, A., PIACENTINI, G. L., & Pecoraro, L. (2024) · Biomedicines · doi:10.3390/biomedicines12081823 · Cited by 3
“Variants in other PKD-related genes, unidentified modifier genes, and environmental factors such as acute kidney injury can modulate cyst formation and disease progression, increasing the likelihood of cystogenesis as PC1 and PC2 levels drop below threshold levels [21,22].”
BackgroundActivation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo
Fan, Q., Hadla, M., Peterson, Z., Nelson, G., Ye, H., Wang, X., Mardirossian, J. M., Harris, P. C., Alper, S. L., Prakash, Y. S., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000598 · Cited by 3
Self-citationImmunohistochemical study of polycystin-1 in dentigerous cysts
Thavarajah, R., Singarayan, J. L., Joshua, E., Rao, U. K., & Ranganathan, K. (2014) · Indian Journal of Dental Research · doi:10.4103/0970-9290.152198 · Cited by 3
“[16] Exosomes have been demonstrated to be linked to PC1 expression[17] and also observed in Ameloblasts.”
BackgroundChanging the Outcome of a Pediatric Disease: Part I — Clinical Features of ADPKD
Cadnapaphornchai, M. A., & Mekahli, D. (2022) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-022-00244-z · Cited by 3
Scarinci, N., Perez, P. L., Cantero, M. D. R., & Cantiello, H. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.11.088336 · Cited by 3
Lee, W., Cheng, B., Lee, C., & Liao, S. (2024) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_77_23 · Cited by 2
The impact of maternal obesity on polycystic kidney disease progression in a mouse model
Miller, S. J., Hill, K. B., Darby, I. G., Nusrat, F., Friedman, J. E., Rudolph, M. C., & Zimmerman, K. A. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00227.2024 · Cited by 2
Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease
Betkar, S., Nemirovski, A., Ruppo, S., Hinden, L., & Tam, J. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01457-w · Cited by 2
“…studies indicate that cystogen-esis in this model is stage-dependent and involves both proximal and distal tubular segments, with a substantial proximal tubule contribution in early disease and persistent cortical tubular dilation at later time points (e.g., 12 months) (Hopp et al. 2012).”
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
Meyer, A., Sotiropoulou, P., Bouker, K., Svedberg, D., Hammar, R., Bange, H., Larsson, P., Mateus, A., Dietrich, D. R., & Artursson, P. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70493 · Cited by 2
“The resulting increased concentration of correctly folded PC1 and PC2 at the cilia could then possibly exceed the threshold below which cystogenesis occurs (Hopp et al., 2012; van Lantinga-Leeuwen et al., 2004).”
Gene editing: a near future for the treatment of genetic kidney diseases
Gómez-García, F., & García-González, M. Á. (2024) · Kidney International · doi:10.1016/j.kint.2024.01.004 · Cited by 2
Paolis, E. D., Raspaglio, G., Ciferri, N., Zangrilli, I., Tenore, C. R., Urbani, A., Ferraro, P. M., Minucci, A., & Concolino, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164682 · Cited by 2
“Some evidence supports that PC1 and PC2 inhibit cystogenesis in a dose-dependent way, and that cystogenesis occurs when the concentration of PC1 or PC2 falls below a certain threshold [17,18].”
BackgroundMonteillet, L., Perrot, G., Evrard, F., Miliano, A. C., Silva, M., Leblond, A., Nguyen, C., Terzi, F., Mithieux, G., & Rajas, F. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000452 · Cited by 2
Houghtaling, S. R., Gombart, S. K., Ho, T.-H., Huang, G., & Beier, D. R. (2024) · Developmental Biology · doi:10.1016/j.ydbio.2024.11.010 · Cited by 2
CRISPR-Cas9 system in autosomal dominant polycystic kidney disease: a comprehensive review
Kang, S.-K., Park, S. J., Lee, M. H., Kronbichler, A., & Shin, J. I. (2025) · Journal of the Korean Society of Pediatric Nephrology · doi:10.3339/ckd.25.008 · Cited by 2
“However, recently, a gene dosage (haploinsufficiency) model hypothesized that complete loss of the PKD gene is unnecessary and that renal cyst formation occurs when the PKD1 dosage falls below a critical threshold [25,26 ].”
Doss, M. C., Mullen, S., Roye, R., Zhou, J., Chumley, P. H., Mrug, E., Wallace, D. P., Qian, F., Harris, P. C., Yoder, B. K., et al. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00295.2022 · Cited by 2
Self-citationBarata, R., Rocha, L., Tavares, I., Pereira, O., Carvalho, F., & Oliveira, J. P. (2024) · The Nephron journals/Nephron journals · doi:10.1159/000534969 · Cited by 2
“Murine models have been successfully used to analyze the genetic mechanisms and pathophysiology of ADPKD, including functional characterization of speci fi c alleles [13], but, unfortunately, issues related to cost and availableness limit their use for the purpose of clinical variant interpretation.”
MethodTerzenidou, M.-E., Patera, F., Macleod, F. M., Ong, A. C. M., & Fragiadaki, M. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06359-9 · Cited by 2
The Polycystins and Polycystic Kidney Disease
Blazer‐Yost, B. L., & Wallace, D. P. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-55454-5_29 · Cited by 2
Germino, G. G., & Guay‐Woodford, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00048-6 · Cited by 2
Graziani, L., Zampatti, S., Carriero, M. L., Minotti, C., Peconi, C., Bengala, M., Giardina, E., & Novelli, G. (2023) · Genes · doi:10.3390/genes14081589 · Cited by 2
“PC-1, which paralleled and further modified the renal phenotype [54].”
BackgroundZainal, H. (2016) · UCL Discovery (University College London) · Cited by 2
Wang, W., Silva, L. M., Wang, H. H., Kavanaugh, M. A., Pottorf, T. S., Allard, B. A., Jacobs, D. T., Dong, R., Cornelius, J. T., Chaturvedi, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.26.061796 · Cited by 2
Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide Agonists
(2024) · doi:10.1101/2024.01.06.574465 · Cited by 1
Saravanabavan, S., & Rangan, G. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012547 · Cited by 1
“The strengths of our study include the use of a double-mutated mouse model; the Pkd1RC/RC hypomorphic mutation that resembles slow disease in humans [34], together with a truncation mutation of the ATM gene [35].”
MethodEstablishment of transgenic pigs overexpressing human PKD2-D511V mutant
Zhang, Y., Xu, S., Jin, Q., Luo, J., Gao, C., Jayaprakash, S., Wang, H., Zhuang, L., & He, J. H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1059682 · Cited by 1
“One of the established missense mutation models is the PKD1R3277C mutation, which has been widely used as the slow progression model of ADPKD (Hopp et al., 2012).”
MethodRobotic Ultrasound and Novel Collagen Analyses for Polycystic Kidney Disease Research Using Mice
Sussman, C. R., Holmes, H. L., Stiller, A. A., Thao, K., Gregory, A., Anaam, D. A., Meloche, R., Mkhaimer, Y. G., Wells, H. H., Vasconcelos, L., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000000000542 · Cited by 1
“16,17 Longitudinal imaging was conducted at three time points spanning mild to established disease.”
Self-citationKuo, I., Lin, M., Tsao, Y., Chiu, Y., & Lee, J. (2025) · Biomedicines · doi:10.3390/biomedicines13030635 · Cited by 1
“…spectrum indicating that a high frequency of a single PKD2 p.Arg803* mutation (17.8% of the cohort) was found with relatively slower kidney function decline [35]. and PKD2 genes that modulate several signaling pathways and inhibit cystogenesis involving intra-cellular calcium control [36–38].”
InfluentialKai, H., Usui, J., Okada, E., Ishii, R., Sato, T., Tamura, T., Nishiyama, H., & Yamagata, K. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101059 · Cited by 1
“27 This may be the reason why the noncleaved form is associated with a better renal prognosis than the truncated form.”
Shinkawa, K., Ishii, A., Kimura, T., Toriu, N., Nakagawa, N., Wada, T., Sakai, K., Endo, S., Yokoi, H., Matsubara, T., et al. (2025) · The Nephron journals/Nephron journals · doi:10.1159/000547625 · Cited by 1
“In autosomal dominant polycystic kidney disease, a major genetic kidney disease that causes ESKD, lengthened renal cilia have been shown to cause primary ciliary dysfunction in humans and mice [22, 23].”
Aypek, H., Balaban, R. F., Huriyet, N., Bulut, E., Çeçener, G., Akgür, S., Görükmez, O., Ünal, U., Özkaya, G., Ersoy, A., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2547306 · Cited by 1
“…respectively. the levels of polycystin-1 negatively correlate with disease progression rate in a dose-dependent manner. as a result, PKD1 truncating mutations are associated with rapid disease progression, while PKD1 non-truncating mutations and PKD2 mutations lead to a slower progression [11].”
Frank, M. S. B., Bennett, M. K., Ha, T., Moore, L., Arts, P., Byrne, A. B., Babic, M., Arriola‐Martinez, L., Toubia, J., Brautigan, P. J., et al. (2025) · Human Genomics · doi:10.1186/s40246-025-00844-4 · Cited by 1
Molecular pathology and cystogenic propensity of the ADPKD Taiwan founder variant
Kimura, L. F., Palomero, O. E., Larmore, M. J., DeCaen, P. G., & Vien, T. N. (2025) · JCI Insight · doi:10.1172/jci.insight.191419 · Cited by 1
“While transgenic mice expressing human disease–associated variants have been reported for PKD1 (17), analogous PKD2 mutations in mouse models are untested.”
Sharova, M., Шумихина, М. В., Prikhodina, L., Morozov, S. L., Bulakh, M. V., Рыжкова, О. П., Pustoshilov, D., & Semenova, N. A. (2025) · Prenatal Diagnosis · doi:10.1002/pd.70029 · Cited by 1
Sharma, N., Zheng, J., Alsawaf, Y., Singha, S. K., Xu, X., Zhang, Y., Vučković, I., Macura, S. I., Hanna, C., Hogan, M. C., et al. (2026) · Kidney360 · doi:10.34067/kid.0000001108 · Cited by 1
“…(F1 progeny of 129S6/SvEvTac [129] WT and C57BL/6J [B6] WT) and male and female Pkd1 RC/RC mice (a mouse model mimicking the human PKD1 variant, p.Arg3277Cys [RC] that develops slowly progressive disease and has preserved renal function for at least 1 year 15,16 ) in the same mixed background.”
D’Amico, S., Dar, U., Eckberg, K., Weisser, I. D., Hossain, C., Bronstein, R. D., & Aboudehen, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-35234-w · Cited by 1
“This hypomorphic mouse model is characterized by a slow-progressing and less severe cystic phenotype that more closely recapitulates the disease course in human ADPKD 26 .”
Liu, M., Zhang, T., Cao, W., Tan, T. J., Ying, D., Wang, H., & Xia, Y. F. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001025 · Cited by 1
Ivanov, V., Wu, A., Crocetti, L., Meng, Z., Shrestha-Maskey, P., Liao, T., Adrianto, I., Guerrini, G., Ortiz, P. A., & Pavlov, T. S. (2026) · Purinergic Signalling · doi:10.1007/s11302-025-10127-1 · Cited by 1
“Animals Mayo Clinic provided Pkd1 RC/RC mice [16], for breeding at the Henry Ford Health System.”
Kidney Volume and Molecular Processes are Dynamic in ADPKD
Tug, A., Zheng, J., Alsawaf, Y., Lutsic, J. J., Rangavajhula, A. S., Sharma, N., Zhang, Y., Vučković, I., Macura, S. I., Hanna, C., et al. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106376 · Cited by 1
“16 Using the baseline image (Figure 2d), the patient was classified as class 1C, and the available trajectory of the htTKV for this patient is shown in Figure 2e.”
Self-citationWei, A., Zhang, Y., 许禹, Schneider, J., Detterman, N., Shu, X., Gregersen, T., Folch, M. N., Li, Y., Chen, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093853 · Cited by 1
Regulation of the PKD2 channel function and associated disease phenotypes by RASSF4
Tian, R., Fang, W., Yuan, W., Li, S., Wu, Y., Dong, X., Liu, W., Kong, J., Deng, X., Zhang, R., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10242-8 · Cited by 1
Structural basis of lipid-dependent allosteric gating mechanisms for PC1-PC2 ion channel
Chen, M., Wang, Z., Shi, Y., Huang, G., Morais, T. D. C., Pillai, A., Wang, Y., Mou, M. A., Jing, D., Fan, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75084-8 · Cited by 1
Wang, J., Cruz, C. N., Walsh, J. D., desRanleau, E., Nikonorova, I. A., & Barr, M. M. (2026) · Genetics · doi:10.1093/genetics/iyag182 · Cited by 1
Ciliary ARL13B Drives Cystogenesis in the Kidney by Its Guanine Nucleotide Exchange Factor Activity
Sciver, R. E. V., Forster, A., Lewis, L. M., & Caspary, T. (2026) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000001238 · Cited by 1
Renal cystic disease: from mechanisms to drug development
Tsai, I.-C., & Katsanis, N. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.03.003 · Cited by 1
ADPKD Channels: The Polycystins
Blazer‐Yost, B. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3366-2_23 · Cited by 1
Tan, Y.-C., Blumenfeld, J. D., & Rennert, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19677-5_6 · Cited by 1
Aberrant Cellular Pathways in PKD
Grazioli, A., Outeda, P., & Watnick, T. J. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7784-0_4 · Cited by 1
Therapies for Childhood Polycystic Kidney Disease
Patil, A., Sweeney, W. E., & Avner, E. D. (2018) · OBM Genetics · doi:10.21926/obm.genet.1804056 · Cited by 1
Taniguchi, Y., Miura, K., Shira, Y., Fujimaru, T., Sohara, E., Yamaguchi, Y., & Hattori, M. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100857 · Cited by 1
“14 In addition, elongation of the kidney primary cilia has also been described in patients with ADPKD.”
BackgroundTrant, J., Sánchez, G., McDermott, J. P., & Blanco, G. V. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114356 · Cited by 1
Gall, É. C.-L., & Harris, P. C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7784-0_1 · Cited by 1
Self-citationAutosomal Dominant Polycystic Kidney Disease
Cadnapaphornchai, M. A., & Mekahli, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_116 · Cited by 1
Deep Transfer Learning from Constrained Source to Target Domains in Medical Image Segmentation
Krishnan, C., Schmidt, E., Onuoha, E. E., Mullen, S., Roye, R., Chumley, P. H., Mrug, M. M., Cárdenas, C., & Kim, H. (2024) · Journal of Imaging Science and Technology · doi:10.2352/j.imagingsci.technol.2024.68.6.060505 · Cited by 1
Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide AgonistsPreprint
Pawnikar, S. P., Magenheimer, B. S., Munoz, E. N., Haldane, A., Maser, R. L., & Miao, Y. (2024) · eLife · doi:10.7554/elife.95992.1 · Cited by 1
Targeting Ogt in ADPKD mitigates metabolic reprogramming and renal cystogenesis, extending survivalPreprint
Kavanaugh, M. A., Ahmad, S., Isai, D. G., Riddle, H. A., Assis, A. P., Ranganathan, C., Chaturvedi, A., Lam, V., Muthineni, N., Abid, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.14.693989 · Cited by 1
“Pkd1 RC/RC mice were a generous gift from Dr. Peter Harris, Mayo Clinic 29 .”
Rümmele, D. (2023) · Cited by 1
Patankar, J. V. (2013) · Clinical Genetics · doi:10.1111/cge.12285
DNA Methylation in Polycystic Kidney Disease and Bio-distribution of the C3-G12 peptide
Bates, M. (2016) · Otago University Research Archive (University of Otago)
Amaral, A. G., Watanabe, E. H., & Onuchic², L. F. (2016) · Revista de Medicina · doi:10.11606/issn.1679-9836.v95ispe2p10-21
Rozycki, M. (2015) · TSpace (University of Toronto)
A study of ADPKD pathogenesis and treatment in zebrafish models
Metzner, A. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Bone Morphogenetic Protein-7 and Its Role in Acute Kidney Injury and Chronic Kidney Failure
Sampath, K. T., Grgurević, L., & Vukičević, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-47507-3_12
Alkhafaji, R. S., Zaidan, H. K., & Al-Saadi, A. H. (2016) · Al-Kufa University Journal for Biology · doi:10.36320/ajb/v8.i3.9305
“Because of these overlaps above, serum urea may not be a sensitive and specific marker for the ADPKD patients without renal failure especially with the presence of a normal finding of serum creatinine level [14].”
BackgroundUrinary Metabolomics to Detect Polycystic Kidney Disease at Early Stage
Obidan, A. M. (2017) · Journal of Bioresource Management
Function and Regulation of TRPP2 and TRPP3, and identification of pore gates of TRP channels
Zheng, W. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r30000c37
Function and Regulation of Polycystin-2 and Epithelial Sodium Channel
Wang, Q. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3pc2tf3t
Walker, R. (2016) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-j1pad0yew
Glucose Transport and Metabolism in Polycystic Kidney Disease
Rodríguez, D. (2016) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-130675
The sense of urinary flow in kidney physiology
Verschuren, E. H. J. (2020) · Radboud Repository (Radboud University)
Radadiya, P. S., Puri, R. V., Magenheimer, B. S., Subramaniam, D., Tran, P. V., Zhu, H., Bolisetty, S., Calvet, J. P., Wallace, D. P., & Sharma, M. (2020) · Preprints.org · doi:10.20944/preprints202002.0416.v1
Amaral, A. G. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-29062020-111929
Silva, L. M. (2018) · KU ScholarWorks (The University of Kansas)
Avances clínicos y genéticos en enfermedades renales hereditarias autosómicas dominantes
Furlano, M. M. (2020) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
THE CENTROSOMAL OFD1 PROTEIN REGULATES AUTOPHAGY INDUCTION
Formisano, U. (2019) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/formisano-umberto_phd2019-01-28
Autosomal Dominant Polycystic Kidney Disease
Cadnapaphornchai, M. A., & Mekahli, D. (2021) · Springer eBooks · doi:10.1007/978-3-642-27843-3_116-1
Metadata
- Authors
- Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Peter C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4257-4273
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484456
- OpenAlex
- W2085346322
- Cited by
- 442
- References
- 112
- Citations by year
- 2026: 34 · 2025: 34 · 2024: 45 · 2023: 43 · 2022: 44 · 2021: 44 · 2020: 38 · 2019: 23 · 2018: 19 · 2017: 20 · 2016: 21 · 2015: 31 · 2014: 26 · 2013: 18
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-058816, DK090728, R01DK044863, P30DK090728, R01DK058816)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- autosomal dominant polycystic kidney disease, polycystin-1, PKD1, hypomorphic allele, dosage dependence, disease severity, cyst formation, knockin mouse model, primary cilia, collecting duct, temperature-sensitive mutants, phenotypic variability
- MeSH terms
- Animals, Disease Models, Animal, Severity of Illness Index, Polycystic Kidney, Autosomal Dominant, Protein Folding, Amino Acid Substitution, Mutation, Missense, Animals, Genetically Modified, TRPP Cation Channels, Mice, Gene Knock-In Techniques, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.